Food and Drug AdministrationImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to FDA main menu
DonateNow
Print this Article


World AIDS Day

Food and Drug Administration - December 1, 2006
Richard Klein & Kimberly Struble


Today, December 1, is World AIDS Day. This year's international theme is "Stop AIDS: Keep the Promise."

Started in 1988, World AIDS Day represents many things to many people. For some, it's about increasing awareness of HIV/AIDS, or an opportunity to remember those lost to AIDS, while others see World AIDS Day as an opportunity to rekindle our commitment to fighting the epidemic. UNAIDS estimates well over 50 Million people have been afflicted worldwide by HIV/AIDS since the start of the epidemic 25 years ago.

Many subscribers to this list serve are personally touched by the epidemic, either through their work, volunteer activities, as patients, or through friends and family affected by the disease. World AIDS Day is a time for all of us to take stock of our accomplishments, and pride in our contribution to the considerable progress that has been made. While many goals remain to be reached, the progress to date has been nothing short of extraordinary.

Over the past 25 years, FDA has worked hard to "keep the promise." In collaboration with our colleagues in industry, academia, and the patient and advocacy communities, FDA has been a part of the great wheel of progress against this disease, and helped to keep the wheel in motion.

FDA's HIV/AIDS-related responsibilities are summarized at http://www.fda.gov/oashi/aids/fdarole.html

A list of the 2006 FDA HIV-related accomplishments can be found at http://www.fda.gov/oashi/aids/listserve/archive.html#2006

A timeline of all significant FDA HIV-related activities is available on the web at http://www.fda.gov/oashi/aids/miles.html

Please take a moment today, December 1, to commemorate World AIDS Day in whatever way is meaningful to you, and take pride in the immense and varied contribution we have all made to the fight against this global pandemic.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration


061201
FD061201


SOURCE: Food and Drug Administration (FDA).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .